These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5757164)

  • 1. [Blood serum beta lipoproteins in thyroid gland diseases].
    Slukhaĭ IuF
    Probl Endokrinol (Mosk); 1968; 14(2):52-4. PubMed ID: 5757164
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
    Tourneur R; Letonturier P; Sénécal P
    Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
    [No Abstract]   [Full Text] [Related]  

  • 3. [The "acute" disappearance of radiothyroxine from the blood of normal, hyperthyroid and hypothyroid subjects].
    Busnardo B; Guido R; Vianello A; Casson F; Varotto L
    Acta Isot (Padova); 1968; 8(3):251-69. PubMed ID: 4901484
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum lipids and lipoproteins before and after treatment of hyperthyroidism].
    Kinalska I; Borejszo I; Szelachowska M; Zimnicki P
    Endokrynol Pol; 1985; 36(5):271-6. PubMed ID: 3841656
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thyroid acropachy with an abnormally high concentration of long acting thyroid stimulator].
    Momotani N; Suzuki T; Harada S; Nishikawa Y; Ito K
    Horumon To Rinsho; 1972 Aug; 20(8):649-53. PubMed ID: 4678862
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum lipoproteins in disorders of thyroid function].
    Richter V; Rassoul F; Homann M; Zuck U; Rotzsch W
    Z Med Lab Diagn; 1987; 28(8):415-20. PubMed ID: 3439269
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunopathogenetic, endocrinologic and therapeutic problems of EMO syndrome. Observations based on a case report].
    Göring HD; Ziemer A
    Dermatol Monatsschr; 1989; 175(8):492-8. PubMed ID: 2792490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frequency of the exophthalmos-producing factor (EPS) in clinical forms of exophthalmos].
    Stancu H; Dancăşiu M; Bălan M; Negoescu I
    Stud Cercet Endocrinol; 1969; 20(2):157-62. PubMed ID: 5394446
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-acting thyroid stimulator].
    Titov VN
    Klin Med (Mosk); 1969 Oct; 47(10):31-9. PubMed ID: 4915396
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of immunosuppressive therapy on the long acting thyroid stimulator (LATS) and the clinical picture in patients with localized myxedema and exophthalmus].
    Depisch D; Höfer R; Schatz H
    Wien Klin Wochenschr; 1969 Jan; 81(1):8-10. PubMed ID: 5818436
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical significance of plasma thyroid-stimulating ctivity in hyperthyroidism.
    Hoffmann MJ; Hetzel BS
    Australas Ann Med; 1966 Aug; 15(3):204-9. PubMed ID: 4169740
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical significance of plasma thyroid-stimulating activity in hyperthyroidism.
    Hoffmann MJ; Hetzel BS
    Australas Ann Med; 1966 Aug; 15(3):204-9. PubMed ID: 4168752
    [No Abstract]   [Full Text] [Related]  

  • 13. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
    Busnardo B; Accordi F; Debiasi S
    Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipoprotein metabolism in patients with disordered thyroid gland function before and following therapy].
    Rassoul F; Richter V; Kuhlmann E; Heberling HJ; Homann M; Zuck U; Rotzsch W; Lohmann D
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(2):104-11. PubMed ID: 3168898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipoprotein symplexes in myxedema and hyperthyroidism].
    WEICKER H
    Acta Endocrinol (Copenh); 1956 May; 22(1):73-86. PubMed ID: 13326173
    [No Abstract]   [Full Text] [Related]  

  • 17. [Automated determination of hormonal iodine in the plasma: methodology, experimental study, clinical application].
    Jaffiol C; Blayac G; Badach L; Vierne Y; Mirouze J
    Rev Fr Endocrinol Clin; 1969; 10(1):7-30. PubMed ID: 5819920
    [No Abstract]   [Full Text] [Related]  

  • 18. [Examination of the blood lipoprotein and glucoprotein content in myxedema treated with triiodothyronine].
    Kliachko VR; Saitgaleeva MSh
    Probl Endokrinol Gormonoter; 1965; 11(5):8-14. PubMed ID: 5872246
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
    Arnold K; Metcalfe R; Weetman AP
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretation of serum tri-iodothyronine levels measured by the sterling technic.
    Wahner HW; Gorman CA
    N Engl J Med; 1971 Feb; 284(5):225-30. PubMed ID: 4992676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.